Literature DB >> 4041661

Exercise performance of subjects with ankylosing spondylitis and limited chest expansion.

C G Elliott, T R Hill, T E Adams, R O Crapo, R M Nietrzeba, R M Gardner.   

Abstract

To examine the mechanism of exercise limitation associated with chest wall restriction (CWR), we compared the ramp (1 W/3 s) exercise performance of six untrained subjects with ankylosing spondylitis (AS) and six healthy subjects matched for age and body size. Subjects with AS had CWR (maximum rib cage expansion : 1.4 +/- 0.2 cm; means +/- sem). The maximum oxygen uptake (VO2max) of AS subjects (2.15 +/- 0.2 1-stpd) was less than their predicted VO2max (2.68 +/- 0.13 1-stpd; p less than 0.03) and the measured VO2max of matched healthy subjects (2.78 +/- 0.22 1-stpd; p less than 0.03). Subjects with AS achieved 95 percent of predicted maximum heart rate, and their maximum voluntary ventilation exceeded their maximum exercise ventilation by at least 15 l X min-1 unless parenchymal pulmonary disease was present. We conclude that maximum ramp exercise performance of AS subjects with CWR is decreased. Deconditioning or cardiovascular impairment rather than ventilatory impairment appears responsible for the observed reduction of VO2max.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4041661

Source DB:  PubMed          Journal:  Bull Eur Physiopathol Respir        ISSN: 0395-3890


  6 in total

1.  High disease activity is related to low levels of physical activity in patients with ankylosing spondylitis.

Authors:  Camilla Fongen; Silje Halvorsen; Hanne Dagfinrud
Journal:  Clin Rheumatol       Date:  2013-07-31       Impact factor: 2.980

2.  Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis.

Authors:  Ayla Çağliyan Türk; Sertaç Arslan; Yusuf Karavelioğlu; Macit Kalcik; Sumru Özel; Ahmet Musmul; Füsun Şahin
Journal:  Arch Rheumatol       Date:  2019-04-22       Impact factor: 1.472

3.  [A comparison of respiratory muscle strength, pulmonary function tests and endurance in patients with early and late stage ankylosing spodylitis].

Authors:  G Sahin; H Guler; M Calikoglu; M Sezgin
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

4.  Treatment of ankylosing spondylitis with biologics and targeted physical therapy: positive effect on chest pain, diminished chest mobility, and respiratory function.

Authors:  Z Gyurcsik; N Bodnár; Z Szekanecz; S Szántó
Journal:  Z Rheumatol       Date:  2013-12       Impact factor: 1.372

5.  Respiratory muscle strength but not BASFI score relates to diminished chest expansion in ankylosing spondylitis.

Authors:  Günşah Sahin; Mukadder Calikoğlu; Cengiz Ozge; Nurgul Incel; Ali Biçer; Bahar Ulşubaş; Hayal Güler
Journal:  Clin Rheumatol       Date:  2004-03-16       Impact factor: 2.980

6.  Reliability of Chest Wall Mobility and Its Correlation with Lung Functions in Healthy Nonsmokers, Healthy Smokers, and Patients with COPD.

Authors:  Ravi S Reddy; Khalid A Alahmari; Paul S Silvian; Irshad A Ahmad; Venkata Nagaraj Kakarparthi; Kanagaraj Rengaramanujam
Journal:  Can Respir J       Date:  2019-02-25       Impact factor: 2.409

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.